What it's for (Indications)
- Used for oedema (swelling) associated with congestive heart failure (heart disorder), hepatic ascites (fluid in abdomen due to liver disorder), and kidney disease where potassium supplementation is required.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The dosage regimen for the fixed-dose combination of spironolactone and furosemide (e.g., Spiromide) must be individualized based on the patient's clinical condition, severity of fluid retention, renal function, and electrolyte status. Typically, for the treatment of edema associated with conditions such as congestive heart failure, cirrhosis with ascites, or nephrotic syndrome, an initial oral dose might be 50 mg spironolactone combined with 20 mg furosemide, administered once daily. Dosing should always commence with the lowest effective dose and be titrated carefully upwards, guided by the therapeutic response, serum electrolyte concentrations (particularly potassium and sodium), and blood pressure monitoring. Due to its diuretic effects, the medication is generally administered in the morning to minimize nocturnal diuresis. Maximum daily doses vary, but close monitoring is paramount to avoid electrolyte imbalances, particularly hyperkalemia with spironolactone and hypokalemia with furosemide, and to prevent acute kidney injury. Adjustment may be necessary in patients with compromised renal or hepatic function. Regular assessment of fluid balance, body weight, and renal parameters is essential throughout therapy. Patients should be advised not to exceed the prescribed dose and to report any adverse effects promptly. |
Safety & Warnings
Common Side Effects
- Patients may experience gynaecomastia (hormone imbalance), gastrointestinal (GI) upset (upset stomach), rash, drowsiness, headache, or confusion.
- Patients should consult their doctor if they experience any of these symptoms.
Serious Warnings
- Black Box Warning: None
- Patients should consult their doctor before taking this medicine if they are pregnant.
- Women who are breastfeeding should avoid taking this medicine.
- Driving should be avoided when taking this medicine as it may affect the ability to drive.
- Patients with kidney and liver impairment should consult their doctor before taking this medicine.
How it Works (Mechanism of Action)
The combination therapy of spironolactone and furosemide offers a synergistic diuretic and anti-aldosterone effect through distinct yet complementary mechanisms of action within the renal tubules. Furosemide, a potent loop diuretic, primarily acts on the thick ascending limb of the loop of Henle. Here, it competitively inhibits the Na+-K+-2Cl- cotransporter, thereby decreasing the reabsorption of these ions and subsequently reducing water reabsorption. This leads to a rapid and significant increase in the excretion of sodium, chloride, potassium, and water, resulting in powerful natriuresis and diuresis. In contrast, spironolactone is a potassium-sparing diuretic and a competitive antagonist of aldosterone at the mineralocorticoid receptors located in the cortical collecting duct and distal convoluted tubule. By blocking aldosterone's action, spironolactone promotes the excretion of sodium and water while simultaneously conserving potassium and hydrogen ions. This dual action not only enhances overall diuresis but also mitigates the potassium-depleting effect commonly associated with loop diuretics like furosemide. Furthermore, spironolactone exerts beneficial anti-fibrotic and anti-remodeling effects independent of its diuretic action, particularly relevant in chronic heart failure. The combined pharmacological approach leads to more effective fluid removal and better electrolyte balance compared to either agent alone, making it particularly useful in refractory edema and conditions with secondary hyperaldosteronism where aldosterone levels are elevated.